Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Modern Approaches to Identifying, Understanding and Controlling Variables and Transfer of Knowledge

14 Apr 2014 - 14 Apr 2014 - BioCity Edinburgh, UK



Bookmark and Share


Validated processes can often fail during the transfer stage and result in non-value added investment of resources to troubleshoot the problems. Two main reasons for this are; either the variables which contribute to inconsistencies of the outcome of the procedure have not been identified or controlled adequately or the transfer of knowledge of the process has not been performed effectively.   Whatever the process may be identifying, understanding and controlling variables is a key strategy towards enabling the process to perform to give a consistent outcome during routine use. In the event the process has to be transferred to a new environment, effective knowledge transfer of the process is vital to success.   There are many courses available today which cover the quality by design approach to developing manufacturing processes and analytical procedures so why should you attend this workshop? A process is a process and this one day practical workshop provides the opportunity to learn and apply the basic skills required to investigate, identify and understand variables, to develop a consistent process and transfer the knowledge of that process successfully. Participants will have the opportunity to use quality by design tools and concepts such as the target profile, risk assessment and control strategy to develop a simple process through experimentation and data analysis and then communicate it effectively to others. The skill set and mindset experienced during the classroom team exercises will provide a solid foundation when dealing with industry processes This workshop was designed to provide hands on experience using QbD tools and concepts such as the target profile, risk assessment and control strategy by applying them in the design and development of a simple process. This is achieved through experimentation with a statapult and/or making “Tasty Tablets”. The actual classroom process(s) will depend on the number and the background of attendees.

Further information
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!